Abstract
This chapter offers a very practical account of the reporting of N-of-1 trials to patients and clinicians, using trials for chronic pain conditions as models which may be applied to many other forms of N-of-1 trials. It draws from the author’s experience in managing N-of-1 trials comparing celecoxib with extended release paracetamol for chronic pain and osteoarthritis and comparing gabapentin with placebo for chronic neuropathic pain. Reporting the results of N-of-1 trials to patients and health care professionals requires considerable planning to make reports user-friendly and an efficient tool for clinical decision making. Decisions need to be made about key elements of the report, how to order them with the most important summary elements first followed by detailed results, and how to set thresholds for clinically important changes. The inclusion of tables and graphs in reports should improve readability. An example of an individual report is provided.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bombardier C, Hayden J, Beaton DE (2001) Minimal clinically important difference low back pain: outcome measures. J Rheumatol 28:431–438
Copay AG, Subach BR, Glassman SD, Polly DW, Schuler TC (2007) Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 7(5):541–546
Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT et al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9:105–121
Jaeschke R, Singer J, Guyatt GH (1989) Measurement of health status. Ascertaining the minimally clinically important difference. Control Clin Trials 10:407–415
Ryan M (2004) Discrete choice experiments in health care. BMJ 328:360–361
Yelland M, Schluter P (2006) Defining worthwhile and desired responses to treatment of chronic low back pain. Pain Med 7(1):38–45
Yelland MJ, Nikles CJ, McNairn N, Del Mar CB, Schluter PJ, Brown RM (2007) Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of N-of-1 trials. Rheumatology (Oxford) 46(1):135–140
Yelland MJ, Poulos CJ, Pillans PI, Bashford GM, Nikles CJ, Sturtevant JM (2009) N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain. Pain Med 10(4):754–761
Zucker DR, Schmid CH, McIntosh MW, D'Agostino RB, Selker HP, Lau J (1997) Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 50(4):401–410
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Yelland, M. (2015). Individual Reporting of N-of-1 Trials to Patients and Clinicians. In: Nikles, J., Mitchell, G. (eds) The Essential Guide to N-of-1 Trials in Health. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7200-6_9
Download citation
DOI: https://doi.org/10.1007/978-94-017-7200-6_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7199-3
Online ISBN: 978-94-017-7200-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)